# The Study of Mesenchymal Stem Cells Treat Autoimmune Pulmonary Alveolar Proteinosis in Vitro

> **NCT05640687** · — · UNKNOWN · sponsor: **Guangzhou Institute of Respiratory Disease** · enrollment: 26 (actual)

## Conditions studied

- Pulmonary Alveolar Proteinosis(PAP)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05640687
- **Lead sponsor:** Guangzhou Institute of Respiratory Disease
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-01
- **Primary completion:** 2023-02-01
- **Final completion:** 2023-04-06
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05640687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05640687, "The Study of Mesenchymal Stem Cells Treat Autoimmune Pulmonary Alveolar Proteinosis in Vitro". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05640687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*